Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...
Assetmark Inc. decreased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 67.7% in the 4th quarter, ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).
This was the stock's second consecutive day of losses.
Zacks Investment Research on MSN17h
Zimmer Biomet Focuses on Innovation Amid Growing CompetitionZimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...
WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...
In the third quarter of 2024, Zimmer Biomet reported sales of $1.82 billion, representing an approximate 4% year-over-year growth and aligning with consensus estimates. The company's adjusted ...
16:58 EST Zimmer Biomet (ZBH) files automatic mixed securities shelf See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for ...
WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, has entered into a strategic distribution agreement with Promamec, a leading provider of medical devices in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback